# TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA

> **NCT04304625** · PHASE3 · RECRUITING · sponsor: **University Hospital, Bordeaux** · enrollment: 1380 (estimated)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** Tranexamic Acid / Sodium chloride

## Key facts

- **NCT ID:** NCT04304625
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-08-07
- **Primary completion:** 2027-06
- **Final completion:** 2027-09
- **Target enrollment:** 1380 (ESTIMATED)
- **Last updated:** 2025-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04304625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04304625, "TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT04304625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*